Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 1, 2025 | Motilal Oswal's Bold Bet on Megafine Pharma: A Strategic Move in the API Landscape | In a significant move that underscores the shifting dynamics of the pharmaceutical industry, Motilal Oswal Alternates (MO Alts) has acquired a majority stake in Megafine Pharma Pvt Ltd for ₹460 crore. This investment marks MO Alts' first ma... |
| Feb 25, 2025 | MO Alts picks up majority stake in API maker Megafine Pharma | Credit: Thinkstock Motilal Oswal Alternates (MO Alts), the private equity arm of Motilal Oswal Financial Services Ltd, has invested Rs 460 crore to acquire a majority stake in active pharmaceutical ingredient (API) manufacturing firm Megafi... |
| Join Ventures | “Join Ventures” |
Reviews 0
FAQ about Join Ventures
What has the press written about Join Ventures?
Parsers VC has collected 4 articles mentioning Join Ventures, among them “Motilal Oswal's Bold Bet on Megafine Pharma: A Strategic Move in the API Landscape” (Mar 1, 2025) and “MO Alts picks up majority stake in API maker Megafine Pharma” (Feb 25, 2025).
Is Join Ventures still active?
Yes, Join Ventures is active; its latest activity on Parsers VC dates from Oct 28, 2025.